End stage renal disease. Chronic kidney disease, stage 5
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: An age range of 18 to 65 years ESRD patients on hemodialysis treatment Perform hemodialysis 3 days a week Absence of any physical abnormalities or bone diseases that interfere with their physical activity Willingness to participate in research
Exclusion criteria
Exclusion criteria: BMI above 30 kg/m Disease (gallstones, cancer, and acute disease) Acute heart accident in the past year Taking any medicine outside the routine treatment protocol of hemodialysis patients Use of oral and injectable nutritional supplements except nephrovit and iron supplements according to the protocol Any allergy to honey and its compounds Leaving the patient with his/her personal consent Smoking, drug addiction or alcohol consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malondialdehyde. Timepoint: At the beginning and end of the study. Method of measurement: kit.;Total antioxidant capacity. Timepoint: At the beginning and end of the study. Method of measurement: kit.;Systolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury manometers.;Diastolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury manometers.;Nutritional status. Timepoint: At the beginning and end of the study. Method of measurement: Food recall and 3-day food record questionnaires.;Anthropometric indicators. Timepoint: At the beginning and end of the study. Method of measurement: Weighing scale, Tape measure, BIA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University